The decision comes as Integral Ad Science announced a strategic move to lower prices for key client contract renewals in exchange for high-volume, exclusive commitments.
As a result of the revised pricing strategy, BMO Capital Markets has decreased its revenue and adjusted EBITDA forecasts for Integral Ad Science for the year 2024 by 2% and 6%, respectively.
[
add
]
[
|
|
...
]